MOD GRF 1-29 - Deus Medical

Sermorelin acetate mimics a portion of naturally occurring (GHRH). This synthetic peptide was developed in the early 1980s and FDA-approved in 1997 for use under the name Geref by Serono. Initially employed to diagnose pituitary dysfunction, it also treated growth hormone deficiency in children. Despite its market withdrawal in 2008, the peptide remains accessible through compounded formulations. Sermorelin promotes controlled growth hormone release, reducing risks associated with excessive supplementation​​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about MOD GRF 1-29 by Deus Medical, consult with your doctor or healthcare professional.